SOURCE-LINKED STUDY SUMMARY
Semaglutide lowers body weight in rodents via distributed neural pathways.
Abstract summarizedQuality not appraised
- What was studied
- This preclinical study examined how semaglutide affected food intake, food preference, body weight, brain access and neural signaling.
- Who / model studied
- The work used rodents, including semaglutide-treated rats. The abstract does not report sample size, comparator groups or study duration.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- Semaglutide reduced food intake and weight without lowering energy expenditure. It reached selected brain regions without crossing the blood-brain barrier.
- Limitations & context
- This was mechanistic preclinical research. It does not establish the same neural effects, weight response or safety in humans, and methodological quality was not appraised.
Read summary source ↗ · Prepared 9/22/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1172/jci.insight.133429